SHG Provides Compensation Analysis to GB Sciences, Inc.
SHG is pleased to announce it has completed a detailed compensation analysis for GB Sciences, Inc., for the benefit of attracting and retaining the senior leadership team. Our analysis was used among management and its advisors.
About GB Sciences, Inc.
GB Sciences is a biopharmaceutical and cannabinoid-based drug development company whose goal is to create patented formulations for safe, standardized, cannabinoid therapies that target a variety of medical conditions in both the pharmaceutical and wellness markets. To learn more about GB Sciences please visit Home - GB Sciences.
Elevate M&A deals by knowing when to bring in specialized valuation and financial analysis. Protect your client's interests and strengthen relationships.
Advisors, guide clients through M&A with early insights. Strengthen relationships, expand services, and ensure optimal outcomes for business owners.
